Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,183,000 | 10,081,000 | 3,182,000 | 1,735,000 | 1,978,000 |
| Marketable Securities | 30,225,000 | 22,318,000 | 23,270,000 | 26,277,000 | 23,991,000 |
| Receivables | 9,357,000 | 10,675,000 | 13,058,000 | 13,380,000 | 14,645,000 |
| Inventories | 6,166,000 | 6,076,000 | 6,610,000 | 8,275,000 | 12,403,000 |
| Income taxes - deferred | 4,624,000 | 6,170,000 | N/A | N/A | N/A |
| Other current assets | 3,689,000 | 9,511,000 | 14,697,000 | 11,346,000 | 1,691,000 |
| TOTAL | $56,244,000 | $64,831,000 | $60,817,000 | $61,013,000 | $61,670,000 |
| Non-Current Assets | |||||
| PPE Net | 12,397,000 | 13,213,000 | 15,921,000 | 18,645,000 | 22,780,000 |
| Investments And Advances | 16,406,000 | 14,149,000 | 9,814,000 | 9,747,000 | 13,122,000 |
| Intangibles | 81,904,000 | 88,807,000 | 95,753,000 | 101,483,000 | 110,391,000 |
| Other Non-Current Assets | 5,150,000 | 4,798,000 | 5,697,000 | 4,126,000 | 4,986,000 |
| TOTAL | $115,857,000 | $120,967,000 | $127,185,000 | $134,001,000 | $151,279,000 |
| Total Assets | $172,101,000 | $185,798,000 | $188,002,000 | $195,014,000 | $212,949,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,027,000 | 6,424,000 | 4,016,000 | 5,603,000 | 5,469,000 |
| Accounts payable and accrued liabilities | 3,234,000 | 2,921,000 | 3,678,000 | 3,994,000 | 4,370,000 |
| Accrued Expenses | 1,792,000 | 1,875,000 | 2,120,000 | 2,080,000 | 2,242,000 |
| Other current liabilities | 9,972,000 | 13,812,000 | 15,066,000 | 14,256,000 | 13,583,000 |
| TOTAL | $23,366,000 | $29,186,000 | $28,909,000 | $28,636,000 | $37,225,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,462,000 | 31,036,000 | 34,926,000 | 38,410,000 | 43,193,000 |
| aiOther Non-Current Liabilities | 15,994,000 | 22,677,000 | 22,645,000 | 21,044,000 | 24,238,000 |
| TOTAL | $72,115,000 | $74,934,000 | $76,472,000 | $78,113,000 | $85,278,000 |
| Total Liabilities | $95,481,000 | $104,120,000 | $105,381,000 | $106,749,000 | $122,503,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,382,925 | 7,189,062 | 7,538,520 | 7,995,220 | 8,070,373 |
| Common Shares | 453,000 | 448,000 | 445,000 | 444,000 | 443,000 |
| Retained earnings | 69,732,000 | 54,240,000 | 46,210,000 | 42,716,000 | 40,426,000 |
| Other shareholders' equity | -2,925,000 | -5,496,000 | -3,656,000 | -2,943,000 | 712,000 |
| TOTAL | $76,620,000 | $81,678,000 | $82,621,000 | $88,265,000 | $90,446,000 |
| Total Liabilities And Equity | $172,101,000 | $185,798,000 | $188,002,000 | $195,014,000 | $212,949,000 |